Janel Corp. is a holding company, which engages in the provision of integrated logistics and freight forwarding services. The company is headquartered in New York City, New York and currently employs 326 full-time employees. The company went IPO on 2002-03-12. The firm operates through three segments: Logistics, Life Sciences and Manufacturing. The firm's Logistics segment consists of various wholly owned subsidiaries. Its Logistics segment is a non-asset based, full- service provider of cargo transportation logistics management services, including freight forwarding via air, ocean and land-based carriers, customs brokerage services, warehousing and distribution services, trucking, and other logistics services. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. The Manufacturing segment consists of Indco, Inc. (Indco), subsidiary of the Company, which manufactures and distributes mixing equipment and apparatus for specific applications within various industries. Indco serves small- to mid-sized businesses.

Компания имеет штаб-квартиру в Нью-Йорке, Нью-Йорк, и в настоящее время работает 326 штатных сотрудников. Компания вышла на IPO в 2002-03-12 годах.

JANL Profile, Market Tickers and Other

JANL profile